Genes regulating MHC class I processing of antigen

Current Opinion in Immunology

Volumn 11, Issue 1, 1999, Pages 82-88

  Van Endert, Peter M ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEASOME; PROTEINASE;

ANTIGEN PRESENTATION; CYTOSOL; ENDOPLASMIC RETICULUM; GENE EXPRESSION REGULATION; NONHUMAN; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN TRANSPORT; QUALITY CONTROL; REVIEW;

EID: 0033001665     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(99)80015-6     Document Type: Article

References (64)

1. Pamer E, Cresswell P Mechanisms of MHC class I-restricted antigen processing. Annu Rev Immunol. 16:1998;323-358.
2. Koopmann JO, Hammerling GJ, Momburg F Generation, intracellular transport and loading of peptides associated with MHC class I molecules. Curr Opin Immunol. 9:1997;80-88.
3. Tanaka K, Tanahashi N, Tsurumi C, Yokota KY, Shimbara N Proteasomes and antigen processing. Adv Immunol. 64:1997;1-38.
4. Griffin TA, Nandi D, Cruz M, Fehling HJ, Kaer LV, Monaco JJ, Colbert RA Immunoproteasome assembly: cooperative incorporation of interferon gamma (IFN-gamma)-inducible subunits. J Exp Med. 187:1998;97-104.
5. Orlowski M, Cardozo C, Michaud C Evidence for the presence of five distinct proteolytic components in the pituitary multicatalytic proteinase complex. Properties of two components cleaving bonds on the carboxyl side of branched chain and small neutral amino acids. Biochemistry. 32:1993;1563-1572.
6. Niedermann G, Grimm R, Geier E, Maurer M, Realini C, Gartmann C, Soll J, Omura S, Rechsteiner MC, Baumeister Wet al. Potential immunocompetence of proteolytic fragments produced by proteasomes before evolution of the vertebrate immune system. J Exp Med. 186:1997;209-220. In this study, proteasomes from yeast and insect cells are shown to generate efficiently several peptides known as high-copy-number epitopes that are presented by MHC class I molecules. Thus, cleavage by proteasomes of polypeptides appears to be highly conserved from yeast to mammalian organisms. IFN-γ-induced or 11S-activator-associated mammalian proteasomes produce increased amounts of these 'presentable' peptides rather than different peptides.
7. Van Kaer L, Ashton-Rickardt PG, Eichelberger M, Gaczynska M, Nagashima K, Rock KL, Goldberg AL, Doherty PC, Tonegawa S Altered peptidase and viral-specific T cell response in LMP2 mutant mice. Immunity. 1:1994;533-541.
8. Fehling HJ, Swat W, Laplace C, Kuhn R, Rajewski K, Muller U, von Boehmer H MHC class I expression in mice lacking the proteasome subunit LMP-7. Science. 265:1994;1234-1237.
9. Eleuteri AM, Kohanski RA, Cardozo C, Orlowski M Bovine spleen multicatalytic proteinase complex (proteasome). Replacement of X, Y, and Z subunits by LMP7, LMP2, and MECL1 and changes in properties and specificity. J Biol Chem. 272:1997;11824-11831.
10. Bogyo M, Shin S, McMaster JS, Ploegh HL Substrate binding and sequence preference of the proteasome revealed by active-site-directed affinity probes. Chem Biol. 5:1998;307-320. Here, a series of tripeptide and tetrapeptide vinyl sulfones are used to study the substrate binding and specificity of the proteasome. By modifying distal positions (e.g. P4) and the carboxyl termini of the vinyl sulfones, relatively specific inhibitors for individual catalytic subunits can be generated.
11. Schmidtke G, Eggers M, Ruppert T, Groettrup M, Koszinowski UH, Kloetzel PM Inactivation of a defined active site in the mouse 20S proteasome complex enhances major histocompatibility complex class I antigen presentation of a murine cytomegalovirus protein. J Exp Med. 187:1998;1641-1646.
12. Anton LC, Snyder HL, Bennink JR, Vinitsky A, Orlowski M, Porgador A, Yewdell JW Dissociation of proteasomal degradation of biosynthesized viral proteins from generation of MHC class I-associated antigenic peptides. J Immunol. 160:1998;4859-4868.
13. Luckey CJ, King GM, Marto JA, Venketeswaran S, Maier BF, Crotzer VL, Colella TA, Shabanowitz J, Hunt DF, Engelhard VH Proteasomes can either generate or destroy MHC class I epitopes: evidence for nonproteasomal epitope generation in the cytosol. J Immunol. 161:1998;112-121.
14. Vinitsky A, Anton LC, Snyder HL, Orlowski M, Bennink JR, Yewdell JW The generation of MHC class I-associated peptides is only partially inhibited by proteasome inhibitors: involvement of nonproteasomal cytosolic proteases in antigen processing? J Immunol. 159:1997;554-564.
15. Niedermann G, Butz S, Ihlenfeldt HG, Grimm R, Lucchiari M, Hoschützky H, Jung G, Maier B, Eichmann K Contribution of proteasome-mediated proteolysis to the hierarchy of epitopes presented by major histocompatibility complex class I molecules. Immunity. 2:1995;289-300.
16. Ossendorp F, Eggers M, Neisig A, Ruppert T, Groettrup M, Sijts A, Mengede E, Kloetzel PM, Neefjes J, Koszinowski Uet al. A single residue exchange within a viral CTL epitope alters proteasome-mediated degradation resulting in lack of antigen presentation. Immunity. 5:1996;115-124.
17. Craiu A, Gaczynska M, Akopian T, Gramm CF, Fenteany G, Goldberg AL, Rock KL Lactacystin and clasto-lactacystin beta-lactone modify multiple proteasome beta-subunits and inhibit intracellular protein degradation and major histocompatibility complex class I antigen presentation. J Biol Chem. 272:1997;13437-13445.
18. Bai A, Forman J The effect of the proteasome inhibitor lactacystin on the presentation of transporter associated with antigen processing (TAP)-dependent and TAP-independent peptide epitopes by class I molecules. J Immunol. 159:1997;2139-2146.
19. Benham AM, Gromme M, Neefjes J Allelic differences in the relationship between proteasome activity and MHC class I peptide loading. J Immunol. 161:1998;83-89.
20. Cerundolo V, Benham A, Braud V, Mukherjee S, Gould K, Macino B, Neefjes J, Townsend A The proteasome-specific inhibitor lactacystin blocks presentation of cytotoxic T lymphocyte epitopes in human and murine cells. Eur J Immunol. 27:1997;336-341.
21. Beninga J, Rock KL, Goldberg AL Interferon-gamma can stimulate post-proteasomal trimming of the N terminus of an antigenic peptide by inducing leucine aminopeptidase. J Biol Chem. 273:1998;18734-18742.
22. Lopez D, Del Val M Selective involvement of proteasomes and cysteine proteases in MHC class I antigen presentation. J Immunol. 159:1997;5769-5772.
23. Glas R, Bogyo M, McMaster JS, Gaczynska M, Ploegh HL A proteolytic system that compensates for loss of proteasome function. Nature. 392:1998;618-622. This provides the strongest and most direct evidence for an additional protease that compensates for a dramatic reduction in proteasome activity. This large protease can sustain normal cell growth and almost normal levels of peptide-assembled MHC class I molecules; it is inhibited by AAF-CMK, a compound known to inhibit serine proteases but not the proteasome.
24. Gubler B, Daniel S, Armandola E, Hammer J, Caillat-Zucman S, van Endert PM Substrate selection by transporters associated with antigen processing occurs during peptide binding to TAP. Mol Immunol. 35:1998;427-433.
25. Van Endert PM, Riganelli D, Greco G, Fleischhauer K, Sidney J, Sette A, Bach J-F The peptide-binding motif for the human transporter associated with antigen processing. J Exp Med. 182:1995;1883-1895.
26. Momburg F, Roelse J, Howard JC, Butcher GW, Hämmerling GJ, Neefjes JJ Selectivity of MHC-encoded peptide transporters from human, mouse and rat. Nature. 367:1994;648-651.
27. Powis SJ, Young LL, Joly E, Barker PJ, Richardson L, Brandt RP, Melief CJ, Howard JC, Butcher GW The rat cim effect: TAP allele-dependent changes in a class I MHC anchor motif and evidence against C-terminal trimming of peptides in the ER. Immunity. 4:1996;159-166.
28. Yellen-Shaw AJ, Laughlin CE, Metrione RM, Eisenlohr LC Murine transporter associated with antigen presentation (TAP) preferences influence class I-restricted T cell responses. J Exp Med. 186:1997;1655-1662. This is a study of the effect of the selectivity of the murine peptide transporter on presentation of cytosolic peptides with variable carboxy-terminal residues that are expressed as minigenes. Only when epitope recognition by cytotoxic T lymphocytes is diminished by antibodies to CD8, or when cytosolic peptide levels are decreased, does peptide selection by TAP become detectable.
29. Joly AL, Le Rolle AL, Gonzalez AL, Mehling WJ, Stevens WJ, Coadwell WJ, Hunig JC, Howard JC, Butcher GW Co-evolution of rat TAP transporters and MHC class I RT1-A molecules. Curr Biol. 8:1998;169-172.
30. Daniel S, Brusic V, Caillat-Zucman S, Petrovsky N, Harrison L, Riganelli D, Sinigaglia F, Gallazzi F, Hammer J, van Endert PM Relationship between peptide selectivities of human transporters associated with antigen processing and HLA class I molecules. J Immunol. 161:1998;617-624. Based on TAP-binding affinity data of a large set of peptides, 'artificial neural networks' are developed here that allow reliable prediction of binding affinities of 9-mer peptides for human TAP. This approach is then used to determine the TAP affinities of >400 peptides binding to various HLA class I alleles. Selectivity of human TAP is shown to favour peptide supply for some class I molecules, especially HLA-B27.
31. Wei ML, Cresswell P HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides. Nature. 356:1992;443-446.
32. Uger RA, Barber BH Presentation of an influenza nucleoprotein epitope incorporated into the H-2Db signal sequence requires the transporter-associated with antigen presentation. J Immunol. 158:1997;685-692.
33. •], this paper suggests that membrane proteins previously thought to be degraded in the ER may in fact frequently be re-exported from this compartment for degradation in the cytosol. It is possible that these proteins exit from the ER via Sec61-mediated retrograde transport.
34. •].
35. Wood P, Elliott T Glycan-regulated antigen processing of a protein in the endoplasmic reticulum can uncover cryptic cytotoxic T cell epitopes. J Exp Med. 188:1998;773-778. This paper shows that several model epitopes can be presented in TAP-deficient cells, and therefore probably be generated in the ER, only when distal N-linked glycosylation sites are eliminated. It is speculated that inhibition of protein degradation in the ER by target-protein glycosylation may protect epitopes that are derived by cytosolic proteolysis from competition with ER-generated peptides for binding to MHC class I molecules.
36. Snyder HL, Bacik I, Bennink JR, Kearns G, Behrens TW, Bachi T, Orlowski M, Yewdell JW Two novel routes of transporter associated with antigen processing (TAP)-independent major histocompatibility complex class I antigen processing. J Exp Med. 186:1997;1087-1098.
37. Yewdell JW, Snyder HL, Bacik I, Anton LC, Deng Y, Behrens TW, Bachi T, Bennink JR TAP-independent delivery of antigenic peptides to the endoplasmic reticulum: therapeutic potential and insights into TAP-dependent antigen processing. J Immunother. 21:1998;127-131.
38. Gabathuler R, Alimonti J, Zhang QJ, Kolaitis G, Reid G, Jefferies WA Surrogate antigen processing mediated by TAP-dependent antigenic peptide secretion. J Cell Biol. 140:1998;17-27.
39. Williams DB, Watts TH Molecular chaperones in antigen presentation. Curr Opin Immunol. 7:1995;77-84.
40. •], this study is among the first to identify ERp57 as a component of MHC class I peptide-loading complexes.
41. Sadasivan B, Lehner P, Ortmann B, Spies T, Cresswell P Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP. Immunity. 5:1996;103-114.
42. Vassilakos A, Cohen-Doyle MF, Peterson PA, Jackson MR, Williams DB The molecular chaperone calnexin facilitates folding and assembly of class I histocompatibility molecules. EMBO J. 15:1996;1495-1506.
43. Prasad SA, Yewdell JW, Porgador A, Sadasivan B, Cresswell P, Bennink JR Calnexin expression does not enhance the generation of MHC class I-peptide complexes. Eur J Immunol. 28:1998;907-913.
44. Vassilakos A, Michalak M, Lehrman MA, Williams DB Oligosaccharide binding characteristics of the molecular chaperones calnexin and calreticulin. Biochemistry. 37:1998;3480-3490.
45. Harris MR, Yu YY, Kindle CS, Hansen TH, Solheim JC Calreticulin and calnexin interact with different protein and glycan determinants during the assembly of MHC class I. J Immunol. 160:1998;5404-5409.
46. Zhang Q, Salter RD Distinct patterns of folding and interactions with calnexin and calreticulin in human class I MHC proteins with altered N-glycosylation. J Immunol. 160:1998;831-837.
47. Lewis J, Elliott T Evidence for successive peptide binding and quality control stages during MHC class I assembly. Curr Biol. 8:1998;717-720.
48. Grandea AG, Androlewicz MJ, Athwal RS, Geraghty DE, Spies T Dependence of peptide binding by MHC class I molecules on their interaction with TAP. Science. 270:1995;105-108.
49. •], this paper reports the molecular cloning of human tapasin. The stoichiometry of TAP, tapasin and MHC class I molecules in peptide-loading complexes is also analysed.
50. •].
51. Herberg JA, Sgouros J, Jones T, Copeman J, Humphray SJ, Sheer D, Cresswell P, Beck S, Trowsdale J Genomic analysis of the Tapasin gene, located close to the TAP loci in the MHC. Eur J Immunol. 28:1998;459-467.
52. Grandea AG, Comber PG, Wenderfer SE, Schoenhals G, Früh K, Monaco JJ, Spies T Sequence, linkage to H2-K, and function of mouse tapasin in MHC class I assembly. Immunogenetics. 48:1998;260-265.
53. Solheim JC, Harris MR, Kindle CS, Hansen TH Prominence of beta 2-microglobulin, class I heavy chain conformation, and tapasin in the interactions of class I heavy chain with calreticulin and the transporter associated with antigen processing. J Immunol. 158:1997;2236-2241.
54. Lehner PJ, Surman MJ, Cresswell P Soluble tapasin restores MHC class I expression and function in the tapasin-negative cell line .220. Immunity. 8:1998;221-231. Two novel functions for tapasin are described here. Full-length tapasin increases TAP levels and thereby peptide translocation into the ER; moreover, soluble tapasin restores class I cell-surface expression without binding TAP. Stabilisation of empty class I dimers or their peptide-binding sites and peptide editing are discussed as explanations for the latter phenomenon.
55. Bouvier M, Wiley DC Structural characterization of a soluble and partially folded class I major histocompatibility heavy chain/beta 2m heterodimer. Nat Struct Biol. 5:1998;377-384. This study finds the peptide-binding domains of empty HLA class I dimers to be in a partially folded state with many properties of a 'molten globule'.
56. Springer S, Doring K, Skipper JC, Townsend AR, Cerundolo V Fast association rates suggest a conformational change in the MHC class I molecule H-2Db upon peptide binding. Biochemistry. 37:1998;3001-3012.
57. Sijts AJ, Pamer EG Enhanced intracellular dissociation of major histocompatibility complex class I-associated peptides: a mechanism for optimizing the spectrum of cell surface-presented cytotoxic T lymphocyte epitopes. J Exp Med. 185:1997;1403-1411. The authors show that a peptide forming unstable complexes with MHC class I dissociates more rapidly from class I molecules when these are retained in the ER. This suggests a mechanism for optimisation or 'editing' of class-I-bound peptides in the ER.
58. Peh CA, Burrows SR, Barnden M, Khanna R, Cresswell P, Moss DJ, McCluskey J HLA-B27-restricted antigen presentation in the absence of tapasin reveals polymorphism in mechanisms of HLA class I peptide loading. Immunity. 8:1998;531-542. This is a study of intracellular peptide assembly of three HLA class I molecules in 721.220 cells; it reveals a surprisingly efficient (but as yet unexplained) peptide assembly of HLA-B27 in the absence of tapasin, as compared to HLA-B8 or -B44.
59. Kropshofer H, Hammerling GJ, Vogt AB How HLA-DM edits the MHC class II peptide repertoire: survival of the fittest? Immunol Today. 18:1997;77-82.
60. •].
61. •].
62. Marusina K, Reid G, Gabathuler R, Jefferies W, Monaco JJ Novel peptide-binding proteins and peptide transport in normal and TAP-deficient microsomes. Biochemistry. 36:1997;856-863. Using photoreactive peptides, three ER proteins and one protein (other than TAP) on the cytosolic face of murine microsomes are shown to bind peptides. Increased peptide binding to p100, the membrane-associated protein on the cytosolic face of the ER, may be secondary to a defect in the TAP-related antigen processing pathway.
63. Simmons WA, Roopenian DC, Summerfield SG, Jones RC, Galocha B, Christianson GJ, Maika SD, Zhou M, Gaskell SJ, Bordoli RSet al. A new MHC locus that influences class I peptide presentation. Immunity. 7:1997;641-651. Starting from the phenomenon of polymorphic presentation of a minor histocompatibility antigen epitope in HLA-B27-transgenic rats and mice, the authors map the responsible locus (cim2) to a ~50-75 kilobase region in the centromeric MHC complex of the mouse. Cim2 is distinct from TAP, LMP and tapasin and has a broad effect on peptide presentation by HLA-B27 and two murine MHC class I molecules.
64. Kulig K, Nandi D, Bacik I, Monaco JJ, Vukmanovic S Physical and functional association of the major histocompatibility complex class I heavy chain alpha3 domain with the transporter associated with antigen processing. J Exp Med. 187:1998;865-874.